Clinical Trial

The Benefits of Wearable AI in Post-Discharge Management of AMI Patients

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 17, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Myocardial infarction (MI) remains a major threat to human health. Although interventional treatment techniques have advanced rapidly, many patients still experience major adverse cardiovascular events (MACE) and require hospital readmission after discharge. Artificial intelligence (AI) based on wearable device data has shown great potential in the diagnosis and management of cardiovascular diseases. This study aims to explore the clinical value of wearable device-based data analysis and AI-driven risk stratification models in post-discharge management of acute myocardial infarction (AMI) patients.
Trial Details
NCT Number NCT07288229
Lead Sponsor RenJi Hospital
Conditions Acute Myocardial Infarction, Heart Failure
Enrollment 200 participants
Start Date 2025-12-30
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-17